Clinical trial

WEgovy Real World Assessment of Weight Loss in Korea

NCT07280221

StatusENROLLING_BY_INVITATION

Study typeOBSERVATIONAL

Start date2025-11-10

PhaseN/A

Study timeline

Study start (actual)2025-11-10Date precision: day

Registry last updated2026-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

SeoulSouth Korea3 BusanSouth Korea2 DaeguSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07280221 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.